Two patients with N3 bladder cancer successfully treated by internal iliac arterial infusion chemotherapy and irradiation: case reports

Am J Clin Oncol. 2001 Feb;24(1):87-90. doi: 10.1097/00000421-200102000-00017.

Abstract

The prognosis of patients with bladder cancer with pelvic lymph node metastasis is poor, and only 30% of them have been reported to achieve 5- and 10-year survival rates. Prognosis of the patients with pelvic lymph node metastasis larger than 5 cm (N3) is especially poor. and no patient has been reported to have survived more than 3 years. The authors report the successful treatment of two patients with pelvic N3 bladder cancer by internal iliac arterial infusion chemotherapy combined with whole-pelvis irradiation.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Carboplatin / administration & dosage
  • Carcinoma, Transitional Cell / drug therapy*
  • Carcinoma, Transitional Cell / pathology
  • Carcinoma, Transitional Cell / radiotherapy*
  • Cisplatin / administration & dosage
  • Doxorubicin / administration & dosage
  • Doxorubicin / analogs & derivatives*
  • Humans
  • Iliac Artery
  • Infusions, Intra-Arterial
  • Lymphatic Metastasis
  • Male
  • Methotrexate / administration & dosage
  • Neoplasm Staging
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / pathology
  • Urinary Bladder Neoplasms / radiotherapy*

Substances

  • Doxorubicin
  • Carboplatin
  • pirarubicin
  • Cisplatin
  • Methotrexate